Strider's Oblique Strain Leaves Braves Rotation in Crisis Mode
The ace is down before a single regular-season pitch is thrown. Spencer Strider will open 2026 on the injured list with an oblique strain, and the Braves are scrambling to patch together a functional rotation.
It was the last thing Braves fans wanted to hear coming out of spring training. Spencer Strider, Atlanta's ace and the pitcher the entire rotation was built around for 2026, will begin the season on the injured list after straining his oblique during a spring training bullpen session. The timing could not be worse for a franchise already operating under significant pitching depth concerns.
Strider's injury history is well-documented at this point. He underwent Tommy John surgery after his dominant 2023 campaign and spent most of 2024 rehabbing. When he finally returned in 2025, flashes of the old Strider were visible, but the Braves were understandably cautious with his workload. Now, with a fresh oblique issue layered on top of that history, the club faces a genuinely difficult situation in terms of managing expectations for his return date.
A Cascade of Pitching Problems
Strider's absence would be difficult to absorb in any context. In the current context, it borders on catastrophic. The Braves were already operating without two of their most promising young arms. Spencer Schwellenbach, who looked like a legitimate rotation piece for years to come, is dealing with his own setback. Hurston Waldrep, another young arm who showed flashes of brilliance in limited big-league action, is also not available for the start of the season.
That trio of absences collapses what was supposed to be a legitimate five-man rotation into something far more uncertain. The Braves entered spring training hoping to answer questions at the back end of the rotation. Now they are asking questions about the front end as well.
The Braves need starting pitching depth, and they need it before the calendar flips to April. The margin for error with this rotation right now is almost nonexistent.
Sale and Lopez Must Carry the Load
With Strider out, the burden falls squarely on veteran Chris Sale and Reynaldo Lopez to anchor the 2026 staff. Sale is 37 years old and has had his own lengthy injury history, which makes leaning on him as the clear number-one starter a proposition that carries genuine risk. He showed he could still pitch at an elite level when healthy, but asking him to be the unquestioned anchor of a rotation for a full 162-game season is a significant ask.
Lopez emerged as a reliable mid-rotation option in 2025 and has the stuff to handle a bigger role. Whether he has the track record and the consistency to handle the number-two slot behind Sale for an extended stretch is a different question. Both pitchers are capable. Neither was recruited to be the entire spine of the rotation.
After Sale and Lopez, the options thin out considerably. The Braves will likely turn to a mix of internal prospects and organizational depth starters to fill the back three spots. That could mean extended auditions for pitchers who were not projected to be in this conversation before spring training began.
The Free Agent Market: Giolito and Cortes
The Braves front office under Alex Anthopoulos has been monitoring the remaining free agent market with increased urgency following the Strider news. Two names that have surfaced prominently in trade and free agent discussions are Lucas Giolito and Nestor Cortes.
Giolito has faced his own injury challenges in recent seasons but remains a pitcher with legitimate front-of-rotation upside when healthy. He offers the kind of experience and strikeout rate that the Braves would desperately value in this situation. Cortes, meanwhile, is a crafty left-hander who generates weak contact and has shown an ability to pitch deep into games when his stuff is working.
Neither option is without risk. Both would represent a significant investment for a team that has already committed considerable payroll to the rest of its roster. But given the alternative, which is sending out a rotation with serious question marks at every slot beyond Sale and Lopez, the Braves may have little choice but to be aggressive on the open market in the coming days.
What Happens When Strider Returns
The silver lining in all of this, if there is one, is that oblique strains typically carry shorter recovery timelines than the elbow injuries that have plagued Strider in the past. A realistic best-case scenario has him back on the mound sometime in May, which would limit his absence to roughly four to six weeks of the regular season.
If the Braves can tread water during that window, keeping their record somewhere in the range of .500 while Strider heals, the back half of the season could look very different. A rotation of Strider, Sale, Lopez, and a healthy Schwellenbach would be genuinely competitive in the NL East. Getting there is the challenge.
For now, the Braves are entering the 2026 season doing something they have rarely done in recent years: improvising. How well they handle the next six weeks could determine whether this season becomes a bounce-back story or another disappointing chapter.